Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults

Abstract Introduction As no standard case definitions for respiratory syncytial virus—associated lower respiratory tract disease (RSV-LRTD) in adults are available, this study analyzed definitions for severe RSV-LRTD from previously published data in hospital and community cohorts of adults with RSV...

Full description

Saved in:
Bibliographic Details
Main Authors: Catherine A. Panozzo, Edward E. Walsh, Zhen Yang, Eleanor Wilson, Jaya Goswami, Sonia K. Stoszek, Adrianna Loback, Tony Ng, Beverly M. Francis, Alana K. Simorellis, Wenmei Huang, Linwei Li, Rebecca Vislay-Wade, Zhe Zheng, Evan J. Anderson, Allison August, Grace Chen, Ann R. Falsey
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Infectious Diseases and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40121-024-01072-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571459859382272
author Catherine A. Panozzo
Edward E. Walsh
Zhen Yang
Eleanor Wilson
Jaya Goswami
Sonia K. Stoszek
Adrianna Loback
Tony Ng
Beverly M. Francis
Alana K. Simorellis
Wenmei Huang
Linwei Li
Rebecca Vislay-Wade
Zhe Zheng
Evan J. Anderson
Allison August
Grace Chen
Ann R. Falsey
author_facet Catherine A. Panozzo
Edward E. Walsh
Zhen Yang
Eleanor Wilson
Jaya Goswami
Sonia K. Stoszek
Adrianna Loback
Tony Ng
Beverly M. Francis
Alana K. Simorellis
Wenmei Huang
Linwei Li
Rebecca Vislay-Wade
Zhe Zheng
Evan J. Anderson
Allison August
Grace Chen
Ann R. Falsey
author_sort Catherine A. Panozzo
collection DOAJ
description Abstract Introduction As no standard case definitions for respiratory syncytial virus—associated lower respiratory tract disease (RSV-LRTD) in adults are available, this study analyzed definitions for severe RSV-LRTD from previously published data in hospital and community cohorts of adults with RSV–associated symptoms. Methods The frequency, sensitivity, and specificity of acute respiratory disease symptoms among hospitalized and community cohorts of adults with RSV were analyzed. RSV-LRTD signs/symptoms assessed included shortness of breath (dyspnea), cough and/or fever, wheezing/rales/rhonchi (abnormal lung sounds by auscultation), sputum production, tachypnea, hypoxemia, and pleuritic chest pain. Results Dyspnea and tachypnea provided the best differentiation between hospitalized and community RSV-positive cases. The severe RSV-LRTD case definition yielding one of the highest and best-balanced sensitivity and specificity was dyspnea paired with either abnormal lung sounds by auscultation, hypoxemia, tachypnea, cough and/or fever, sputum, or chest pain. Conclusions Dyspnea alone, and in combination with certain other lower respiratory tract disease signs/symptoms, was a leading symptomatic indicator for severe RSV outcomes. These results contribute to the harmonization of case definitions for RSV disease.
format Article
id doaj-art-900087d595774a10b3c20827c8e17df6
institution Kabale University
issn 2193-8229
2193-6382
language English
publishDate 2024-11-01
publisher Adis, Springer Healthcare
record_format Article
series Infectious Diseases and Therapy
spelling doaj-art-900087d595774a10b3c20827c8e17df62025-02-02T12:35:19ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822024-11-0114127528110.1007/s40121-024-01072-4Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in AdultsCatherine A. Panozzo0Edward E. Walsh1Zhen Yang2Eleanor Wilson3Jaya Goswami4Sonia K. Stoszek5Adrianna Loback6Tony Ng7Beverly M. Francis8Alana K. Simorellis9Wenmei Huang10Linwei Li11Rebecca Vislay-Wade12Zhe Zheng13Evan J. Anderson14Allison August15Grace Chen16Ann R. Falsey17Infectious Disease Clinical Development, Moderna, Inc.Department of Medicine, University of RochesterData Science and Artificial Intelligence, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Data Science and Artificial Intelligence, Moderna, Inc.Data Science and Artificial Intelligence, Moderna, Inc.Medical Affairs, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Clinical Development Operations, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Data Science and Artificial Intelligence, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Infectious Disease Clinical Development, Moderna, Inc.Department of Medicine, University of RochesterAbstract Introduction As no standard case definitions for respiratory syncytial virus—associated lower respiratory tract disease (RSV-LRTD) in adults are available, this study analyzed definitions for severe RSV-LRTD from previously published data in hospital and community cohorts of adults with RSV–associated symptoms. Methods The frequency, sensitivity, and specificity of acute respiratory disease symptoms among hospitalized and community cohorts of adults with RSV were analyzed. RSV-LRTD signs/symptoms assessed included shortness of breath (dyspnea), cough and/or fever, wheezing/rales/rhonchi (abnormal lung sounds by auscultation), sputum production, tachypnea, hypoxemia, and pleuritic chest pain. Results Dyspnea and tachypnea provided the best differentiation between hospitalized and community RSV-positive cases. The severe RSV-LRTD case definition yielding one of the highest and best-balanced sensitivity and specificity was dyspnea paired with either abnormal lung sounds by auscultation, hypoxemia, tachypnea, cough and/or fever, sputum, or chest pain. Conclusions Dyspnea alone, and in combination with certain other lower respiratory tract disease signs/symptoms, was a leading symptomatic indicator for severe RSV outcomes. These results contribute to the harmonization of case definitions for RSV disease.https://doi.org/10.1007/s40121-024-01072-4Case definitionsLower respiratory tract diseaseOlder adultsRespiratory syncytial virusSevere respiratory syncytial virus
spellingShingle Catherine A. Panozzo
Edward E. Walsh
Zhen Yang
Eleanor Wilson
Jaya Goswami
Sonia K. Stoszek
Adrianna Loback
Tony Ng
Beverly M. Francis
Alana K. Simorellis
Wenmei Huang
Linwei Li
Rebecca Vislay-Wade
Zhe Zheng
Evan J. Anderson
Allison August
Grace Chen
Ann R. Falsey
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
Infectious Diseases and Therapy
Case definitions
Lower respiratory tract disease
Older adults
Respiratory syncytial virus
Severe respiratory syncytial virus
title Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
title_full Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
title_fullStr Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
title_full_unstemmed Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
title_short Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
title_sort leveraging real world evidence to define severe rsv lower respiratory tract disease in adults
topic Case definitions
Lower respiratory tract disease
Older adults
Respiratory syncytial virus
Severe respiratory syncytial virus
url https://doi.org/10.1007/s40121-024-01072-4
work_keys_str_mv AT catherineapanozzo leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT edwardewalsh leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT zhenyang leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT eleanorwilson leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT jayagoswami leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT soniakstoszek leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT adriannaloback leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT tonyng leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT beverlymfrancis leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT alanaksimorellis leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT wenmeihuang leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT linweili leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT rebeccavislaywade leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT zhezheng leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT evanjanderson leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT allisonaugust leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT gracechen leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults
AT annrfalsey leveragingrealworldevidencetodefineseverersvlowerrespiratorytractdiseaseinadults